European Medicines Evaluation Agency.
- Published in:
- Indian Journal of Pharmacology, 2004, v. 36, n. 1, p. 50
- By:
- Publication type:
- Article
Works matching DE "EUROPEAN Union. European Medicines Evaluation Agency"
Results: 10
1
2
EMEA Tackles ‘Generic’ Biologic Drug Issues.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 7, p. 435, doi. 10.1093/jnci/djj145
- By:
- Publication type:
- Article
3
Biosimilars; the boundaries of obviousness; and a caution on experiments conducted for litigation.
- Published in:
- Journal of Generic Medicines, 2006, v. 3, n. 3, p. 233, doi. 10.1057/palgrave.jgm.4940124
- By:
- Publication type:
- Article
4
Biosimilars: the impact of their heterogeneity on regulatory approval.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 1, doi. 10.1038/nrd2093-c1
- By:
- Publication type:
- Article
5
Batches of strangles vaccine withdrawn.
- Published in:
- Veterinary Record: Journal of the British Veterinary Association, 2007, v. 160, n. 4, p. 104, doi. 10.1136/vr.160.4.104
- Publication type:
- Article
6
An Agency Fore-warned Is an Agency Fore-armed.
- Published in:
- Applied Clinical Trials, 2004, v. 13, n. 3, p. 30
- By:
- Publication type:
- Article
7
First transgenic drug.
- Published in:
- Chemistry & Industry, 2006, n. 12, p. 6
- Publication type:
- Article
8
The review of drug applications submitted to the European Medicines Evaluation Agency: frequently raised objections, and outcome.
- Published in:
- European Journal of Clinical Pharmacology, 2002, v. 58, n. 9, p. 573, doi. 10.1007/s00228-002-0532-8
- By:
- Publication type:
- Article
9
FDA and EMEA pool scientific advice.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 12, p. 1490, doi. 10.1038/nbt1204-1490
- By:
- Publication type:
- Article
10
Decisions by regulatory agencies: are they evidence-based?
- Published in:
- Trials, 2007, v. 8, p. 1, doi. 10.1186/1745-6215-8-13
- By:
- Publication type:
- Article